A quantitative atlas of histone modification signatures from human cancer cells
Gary LeRoy(Howard Hughes Medical Institute), Benjamin A. García(Princeton University), Sherry Liu(Translational Therapeutics (United States)), Yibin Kang(Rutgers, The State University of New Jersey), Andrés Blanco(Princeton University), Barry M. Zee(Boston Children's Hospital), Barbara M. Bryant(Millennium Engineering and Integration (United States)), Ian Z. Flaniken(Princeton University), Peter A. DiMaggio(Imperial College London), Eric Y. Chan(Constellation Pharmaceuticals (United States)), Patrick Trojer(Morpho (United States))
Cited by 151
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
A multigenic program mediating breast cancer metastasis to bone
|Cancer Cell|2003|2.6k
Guidelines and definitions for research on epithelial–mesenchymal transition
|Nature Reviews Molecular Cell Biology|2020|2.3k
Pre-metastatic niches: organ-specific homes for metastases
|Nature reviews. Cancer|2017|1.9k